GREENLAND MINES LTD Interest Expense
GREENLAND MINES LTD (GRML) reported Interest Expense of $1.61 thousand for the 3-month period ending 2026-03-31, per its 10-Q/A filed 2026-08-14.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-08-14
- GREENLAND MINES LTD interest expense for the quarter ending 2026-03-31 was $1.61K, a 99.71% decline year-over-year.
- GREENLAND MINES LTD interest expense for the quarter ending 2025-03-31 was $553.94K.
| Period end | Interest Expense 3 month |
|---|---|
| 2026-03-31 | $1.61K 10-Q/A · filed 2026-08-14 |
| 2025-03-31 | $553.94K 10-Q/A · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |